SCHEMBL3197360

SCHEMBL3197360

CC(=O)N1CC[C@@H](c2ccc(-c3ccccc3)cc2)[C@H](N)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 5/20 0.47
MAOB P27338 2/20 0.47
RORC P51449 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
ALOX12 P18054 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TACR2 P21452 1/20 0.42
TACR1 P25103 1/20 0.42
TAC3 Q9UHF0 1/20 0.42
SLC6A2 P23975 3/20 0.41
SLC6A4 P31645 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3193851 0.89 KDM1A (0.47) KDM1AMAOBRORCSMN1; SMN2NPC1
SCHEMBL3193309 0.83 USP30 (0.57) RORCTACR1
SCHEMBL3193298 0.83 USP30 (0.57) RORCTACR1
SCHEMBL3193318 0.83 USP30 (0.57) RORCTACR1
SCHEMBL19972344 0.81 FPR1 (0.54) KDM1AMAOBALDH1A1MAOA
SCHEMBL19972346 0.81 FPR1 (0.54) KDM1AMAOBALDH1A1MAOA
SCHEMBL19985876 0.81 FPR1 (0.54) KDM1AMAOBALDH1A1MAOA
SCHEMBL26772714 0.80 RAB9A (0.54) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
Hydrochloric Acid SCHEMBL19972276 0.80 FPR1 (0.53) KDM1AMAOBALDH1A1MAOA
Hydrochloric Acid SCHEMBL19972275 0.80 FPR1 (0.53) KDM1AMAOBALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035865-A1 Sulfonamides and Pharmaceutical Compositions Thereof PFIZER INC 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035865-A1 Sulfonamides and Pharmaceutical Compositions Thereof STS, SULT2A1, SULT1A1 KDM1A 1525/4885MAOB 2542/4885RORC 2651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.